Holdings of ProShares Ultra Nasdaq Biotechnology
ProShares Trust ·260 declared positions · as of Feb 28, 2026
Original filing · Net assets 91.7M $ · Ten largest lines: 46.7 % of the equity sleeve
Sector breakdown
- Health care 49.1 %
- Materials 2.8 %
- Industrials 1.0 %
- Unattributed 47.1 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 89.4 %
- NL 2.2 %
- BM 1.5 %
- FR 1.5 %
- IE 1.3 %
- DK 1.2 %
- DE 0.8 %
- CA 0.6 %
- CH 0.4 %
- KY 0.3 %
- SG 0.2 %
- JE 0.1 %
- Other countries 0.4 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 224 | 55.3M $ | 89.45 % |
| 2 | NL | 4 | 1.3M $ | 2.17 % |
| 3 | BM | 1 | 929.4K $ | 1.50 % |
| 4 | FR | 2 | 925.2K $ | 1.50 % |
| 5 | IE | 4 | 826.8K $ | 1.34 % |
| 6 | DK | 2 | 741.4K $ | 1.20 % |
| 7 | DE | 1 | 514.7K $ | 0.83 % |
| 8 | CA | 4 | 369.8K $ | 0.60 % |
| 9 | CH | 2 | 278.2K $ | 0.45 % |
| 10 | KY | 5 | 160K $ | 0.26 % |
| 11 | SG | 1 | 107.6K $ | 0.17 % |
| 12 | JE | 1 | 70.7K $ | 0.11 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Gilead Sciences Inc | 39,904 | 5.9M $ | 6.48 % |
| 2 | Vertex Pharmaceuticals Inc | 11,581 | 5.8M $ | 6.27 % |
| 3 | Amgen Inc | 14,536 | 5.6M $ | 6.15 % |
| 4 | Regeneron Pharmaceuticals, Inc. | 4,769 | 3.7M $ | 4.06 % |
| 5 | Alnylam Pharmaceuticals Inc | 6,101 | 2M $ | 2.21 % |
| 6 | Insmed Inc | 9,848 | 1.5M $ | 1.60 % |
| 7 | Biogen Inc | 6,774 | 1.3M $ | 1.42 % |
| 8 | Argenx SE | 1,344 | 1M $ | 1.12 % |
| 9 | United Therapeutics Corp | 1,988 | 1M $ | 1.09 % |
| 10 | Moderna Inc | 18,039 | 966.3K $ | 1.05 % |
| 11 | Illumina Inc | 7,055 | 948.6K $ | 1.03 % |
| 12 | Roivant Sciences Ltd | 32,114 | 929.4K $ | 1.01 % |
| 13 | Incyte Corp | 9,065 | 918K $ | 1.00 % |
| 14 | Royalty Pharma PLC | 19,729 | 911.7K $ | 0.99 % |
| 15 | Revolution Medicines Inc | 8,927 | 910.7K $ | 0.99 % |
| 16 | Viatris Inc | 53,183 | 794K $ | 0.87 % |
| 17 | Ascendis Pharma A/S | 2,835 | 662K $ | 0.72 % |
| 18 | Neurocrine Biosciences Inc | 4,604 | 608.9K $ | 0.66 % |
| 19 | Ionis Pharmaceuticals Inc | 7,479 | 606.9K $ | 0.66 % |
| 20 | Sanofi SA | 12,219 | 594.6K $ | 0.65 % |
| 21 | Bridgebio Pharma Inc | 8,897 | 591.5K $ | 0.64 % |
| 22 | Medpace Holdings Inc | 1,301 | 587.7K $ | 0.64 % |
| 23 | Summit Therapeutics Inc | 34,375 | 570.3K $ | 0.62 % |
| 24 | Guardant Health Inc | 5,974 | 561K $ | 0.61 % |
| 25 | BioMarin Pharmaceutical Inc | 8,871 | 547.6K $ | 0.60 % |
| 26 | Exelixis Inc | 12,381 | 545.5K $ | 0.59 % |
| 27 | Jazz Pharmaceuticals PLC | 2,806 | 533.2K $ | 0.58 % |
| 28 | BioNTech SE | 4,669 | 514.7K $ | 0.56 % |
| 29 | BEONE MEDICINES LTD | 1,454 | 460.9K $ | 0.50 % |
| 30 | Madrigal Pharmaceuticals Inc | 1,048 | 452.7K $ | 0.49 % |
| 31 | ImmunityBio Inc | 45,481 | 444.8K $ | 0.49 % |
| 32 | Tempus AI Inc | 7,982 | 425K $ | 0.46 % |
| 33 | Arrowhead Pharmaceuticals Inc | 6,271 | 396.8K $ | 0.43 % |
| 34 | Praxis Precision Medicines Inc | 1,155 | 388.9K $ | 0.42 % |
| 35 | Axsome Therapeutics Inc | 2,327 | 381.4K $ | 0.42 % |
| 36 | Halozyme Therapeutics Inc | 5,430 | 377.5K $ | 0.41 % |
| 37 | Vaxcyte Inc | 6,044 | 373.2K $ | 0.41 % |
| 38 | Krystal Biotech Inc | 1,339 | 369.1K $ | 0.40 % |
| 39 | Cytokinetics Inc | 5,646 | 351.3K $ | 0.38 % |
| 40 | Nuvalent Inc | 3,335 | 340K $ | 0.37 % |
| 41 | Abivax SA | 2,726 | 330.6K $ | 0.36 % |
| 42 | Arcellx Inc | 2,670 | 303.8K $ | 0.33 % |
| 43 | Kymera Therapeutics Inc | 3,322 | 303.5K $ | 0.33 % |
| 44 | Rhythm Pharmaceuticals Inc | 3,082 | 285.8K $ | 0.31 % |
| 45 | Cogent Biosciences Inc | 7,088 | 275.4K $ | 0.30 % |
| 46 | Protagonist Therapeutics Inc | 2,887 | 265.8K $ | 0.29 % |
| 47 | CRISPR Therapeutics AG | 4,400 | 264.6K $ | 0.29 % |
| 48 | Caris Life Sciences Inc | 13,029 | 262.4K $ | 0.29 % |
| 49 | PTC Therapeutics Inc | 3,707 | 252.8K $ | 0.28 % |
| 50 | Alkermes PLC | 7,624 | 229.5K $ | 0.25 % |
| 51 | Immunovant Inc | 8,094 | 224.4K $ | 0.24 % |
| 52 | CG oncology Inc | 3,725 | 219K $ | 0.24 % |
| 53 | Mirum Pharmaceuticals Inc | 2,373 | 219K $ | 0.24 % |
| 54 | Scholar Rock Holding Corp | 4,710 | 208.5K $ | 0.23 % |
| 55 | Amicus Therapeutics Inc | 14,247 | 204.7K $ | 0.22 % |
| 56 | Amneal Pharmaceuticals Inc | 14,516 | 200.5K $ | 0.22 % |
| 57 | Structure Therapeutics Inc | 3,086 | 194.4K $ | 0.21 % |
| 58 | ACADIA Pharmaceuticals Inc | 7,812 | 191.9K $ | 0.21 % |
| 59 | Indivior Pharmaceuticals Inc | 5,763 | 188.6K $ | 0.21 % |
| 60 | Newamsterdam Pharma Co NV | 5,236 | 185.7K $ | 0.20 % |
| 61 | Ligand Pharmaceuticals Inc | 909 | 180.3K $ | 0.20 % |
| 62 | Crinetics Pharmaceuticals Inc | 4,382 | 180.1K $ | 0.20 % |
| 63 | Erasca Inc | 13,101 | 179K $ | 0.20 % |
| 64 | Apogee Therapeutics Inc | 2,532 | 177.2K $ | 0.19 % |
| 65 | Terns Pharmaceuticals Inc | 4,160 | 175.2K $ | 0.19 % |
| 66 | ADMA Biologics Inc | 10,990 | 171.1K $ | 0.19 % |
| 67 | Xenon Pharmaceuticals Inc | 3,568 | 154.2K $ | 0.17 % |
| 68 | Spyre Therapeutics Inc | 3,583 | 154.1K $ | 0.17 % |
| 69 | Arcutis Biotherapeutics Inc | 5,656 | 152.5K $ | 0.17 % |
| 70 | Edgewise Therapeutics Inc | 4,889 | 148.8K $ | 0.16 % |
| 71 | Tarsus Pharmaceuticals Inc | 1,961 | 148.1K $ | 0.16 % |
| 72 | Supernus Pharmaceuticals Inc | 2,648 | 144.9K $ | 0.16 % |
| 73 | Denali Therapeutics Inc | 6,772 | 143.4K $ | 0.16 % |
| 74 | Veracyte Inc | 3,650 | 133.6K $ | 0.15 % |
| 75 | Beam Therapeutics Inc | 4,685 | 133.3K $ | 0.15 % |
| 76 | Alumis Inc | 4,489 | 133.3K $ | 0.15 % |
| 77 | Twist Bioscience Corp | 2,823 | 132.5K $ | 0.14 % |
| 78 | Ideaya Biosciences Inc | 4,048 | 130.3K $ | 0.14 % |
| 79 | 10X Genomics Inc | 5,379 | 124K $ | 0.14 % |
| 80 | Travere Therapeutics Inc | 4,131 | 123.1K $ | 0.13 % |
| 81 | Apellis Pharmaceuticals Inc | 5,839 | 122.4K $ | 0.13 % |
| 82 | Vera Therapeutics Inc | 2,950 | 120.3K $ | 0.13 % |
| 83 | CENTESSA PHARMACEUTICALS PLC | 4,455 | 119.7K $ | 0.13 % |
| 84 | Disc Medicine Inc | 1,744 | 116.2K $ | 0.13 % |
| 85 | Adaptive Biotechnologies Corp | 7,049 | 112.9K $ | 0.12 % |
| 86 | WaVe Life Sciences Ltd | 7,723 | 107.6K $ | 0.12 % |
| 87 | Mineralys Therapeutics Inc | 3,654 | 106.9K $ | 0.12 % |
| 88 | Ultragenyx Pharmaceutical Inc | 4,455 | 104.2K $ | 0.11 % |
| 89 | Dyne Therapeutics Inc | 6,595 | 103K $ | 0.11 % |
| 90 | Maze Therapeutics Inc | 2,222 | 101.3K $ | 0.11 % |
| 91 | Stoke Therapeutics Inc | 2,638 | 96K $ | 0.10 % |
| 92 | GRAIL Inc | 1,800 | 95.8K $ | 0.10 % |
| 93 | Kiniksa Pharmaceuticals International Plc | 2,086 | 92.8K $ | 0.10 % |
| 94 | Harrow Inc | 1,710 | 92.6K $ | 0.10 % |
| 95 | Ocular Therapeutix Inc | 9,837 | 87.9K $ | 0.10 % |
| 96 | Olema Pharmaceuticals Inc | 3,632 | 87.9K $ | 0.10 % |
| 97 | Syndax Pharmaceuticals Inc | 4,014 | 87.1K $ | 0.10 % |
| 98 | Recursion Pharmaceuticals Inc | 23,743 | 87.1K $ | 0.10 % |
| 99 | Aurinia Pharmaceuticals Inc | 6,088 | 86.3K $ | 0.09 % |
| 100 | BioCryst Pharmaceuticals Inc | 9,722 | 85.1K $ | 0.09 % |